Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 1.736
5-Year Impact Factor – 2.135
Index Copernicus  – 168.52
MEiN – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2019, vol. 28, nr 10, October, p. 1301–1309

doi: 10.17219/acem/103845

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Impact of chronic wounds of various etiology on systemic profiles of key inflammatory cytokines, chemokines and growth factors, and their interplay

Małgorzata Krzystek-Korpacka1,, Krzysztof Kędzior1,C,E,F, Leszek Masłowski2,A,B,E,F, Magdalena Mierzchała1,, Iwona Bednarz-Misa1,C,D,F, Agnieszka Bronowicka-Szydełko1,B,E,F, Joanna Kubiak2,B,E,F, Małgorzata Gacka3,B,E,F, Sylwia Płaczkowska4,C,E,F, Andrzej Gamian1,A,E,F

1 Department of Medical Biochemistry, Faculty of Medicine, Wroclaw Medical University, Poland

2 Department of Angiology, Regional Specialist Hospital, Wrocław, Poland

3 Department of Angiology, Hypertension and Diabetes, Wrocław Medical University, Poland

4 Department of Professional Training in Clinical Chemistry, Wroclaw Medical University, Poland


Background. Non-healing wounds are becoming a growing concern for public health as a result of their increasing prevalence in progressively aging societies.
Objectives. The aim of this article is to evaluate the effects of wound etiology on a panel of circulating cytokines in patients with non-healing wounds of the lower extremities.
Material and Methods. This prospective case-control study involved 104 individuals: healthy elderly people (n = 46) and patients with diabetes and/or cardiovascular disease (n = 58; among them 38 with chronic wounds of venous, ischemic or neurotrophic etiology). Selected serum cytokines – i.e. IL-1β, IL-4, IL-6, IL-8, FGF-2, G-CSF, GM-CSF, MCP-1, MIP-1α, TNF-α, VEGF-A, and PDGF-BB – were measured using the Luminex platform.
Results. Compared to healthy elderly people, presence of diabetes and/or cardiovascular disease was associated with elevated IL-6, IL-8, MCP-1 and G-CSF while non-healing wounds coexisted with the increase in the levels of all examined cytokines/growth factors except for G-CSF and GM-CSF. Among diseased elderly people, having wounds was associated with increased levels of IL-1β, IL-4, IL-6, IL-8, FGF-2, MIP-1α, PDGF-BB, and VEGF-A. Interleukin 1β elevation was a sole independent predictor of chronic wounds with an odds ratio (OR) of 6.3. Cytokines in healthy seniors were loosely interrelated, while the levels of cytokines in diseased patients with wounds displayed a tight pattern of association. When stratified by their etiology, the association pattern for IL-6, IL-8, MCP-1, and VEGF-A was disrupted in neurotrophic wounds.
Conclusion. The results presented herein may improve our understanding of the pathomechanisms which lead to chronic wounds and of the effects they exert on a systemic level, as well as providing potential targets for more effective therapies.

Key words

diabetes, venous stasis, ischemic wounds, neurotrophic wounds, inflammation

References (40)

  1. Rayner R, Carville K, Keaton J, Prentice J, Santamaria N. Leg ulcers: Atypical presentations and associated comorbidities. Wound Practice and Research. 2009;17:168–185.
  2. Green J, Jester R, McKinley R, Pooler A. The impact of chronic venous leg ulcers: A systematic review. J Wound Care. 2014;23(12):601–612.
  3. de Lalla F, Pellizzer G, Strazzabosco M, et al. Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection. Antimicrob Agents Chemother. 2001;45(4):1094–1098.
  4. Guo S, DiPietro LA. Factors affecting wound healing. J Dent Res. 2010;89(3):219–229.
  5. Mustoe TA, O’Shaughnessy K, Kloeters O. Chronic wound pathogenesis and current treatment strategies: A unifying hypothesis. Plast Reconstr Surg. 2006;117(7 Suppl):35S–41S.
  6. Wong VW, Crawford JD. Vasculogenic cytokines in wound healing. Biomed Res Int. 2013;2013:190486.
  7. Tuttolomondo A, La Placa S, Di Raimondo D, et al. Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity. Cardiovasc Diabetol. 2010;9:50.
  8. Iversen MM, Tell GS, Riise T, et al. History of foot ulcer increases mortality among individuals with diabetes: Ten-year follow-up of the Nord-Trøndelag Health Study, Norway. Diabetes Care. 2009;32(12):2193–2199.
  9. Escandon J, Vivas AC, Tang J, Rowland KJ, Kirsner RS. High mortality in patients with chronic wounds. Wound Rep Reg. 2011;19(4):526–528.
  10. Zillmer R, Trøstrup H, Karlsmark T, Ifversen P, Agren MS. Duration of wound fluid secretion from chronic venous leg ulcers is critical for interleukin-1a, interleukin-1b, interleukin-8 levels and fibroblast activation. Arch Dermatol Res. 2011;303(8):601–606.
  11. Trøstrup H, Bjarnsholt T, Kirketerp-Møller K, Høiby N, Moser C. What is new in the understanding of non-healing wounds epidemiology, patho-physiology, and therapies. Ulcers. 2013;2013:625934.
  12. Trøstrup H, Lundquist R, Christensen LH, et al. S100A8/A9 deficiency in nonhealing venous leg ulcers uncovered by multiplexed antibody microarray profiling. Br J Dermatol. 2011;165(2):292–301.
  13. Eming SA, Koch M, Krieger A, et al. Differential proteomic analysis distinguishes tissue repair biomarker signatures in wound exudates obtained from normal healing and chronic wounds. J Proteome Res. 2010;9(9):4758–4766.
  14. Panee J. Monocyte chemoattractant protein 1 (MCP-1) in obesity and diabetes. Cytokine. 2012;60(1):1–12.
  15. Kim CS, Park HS, Kawada T, et al. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int J Obes (Lond). 2006;30(9):1347–1355.
  16. Su D, Li Z, Li X, et al. Association between serum interleukin-6 concentration and mortality in patients with coronary artery disease. Mediators Inflamm. 2013;2013:726178.
  17. Souza JR, Oliveira RT, Blotta MH, Coelho OR. Serum levels of interleukin-6 (IL-6), interleukin-18 (IL-18) and C-reactive protein (CRP) in patients with type-2 diabetes and acute coronary syndrome without ST-segment elevation. Arq Bras Cardiol. 2008;90(2):86–90.
  18. Apostolakis S, Vogiatzi K, Amanatidou V, Spandidos DA. Interleukin 8 and cardiovascular disease. Cardiovasc Res. 2009;84(3):353–360.
  19. Koenig W, Khuseyinova N. Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol. 2007;27(1):15–26.
  20. Amasyali B, Kose S, Kursaklioglu H, Barcina C, Kilicb A. Monocyte chemoattractant protein-1 in acute coronary syndromes: Complex vicious interaction. Int J Cardiol. 2009;136(3):356–357.
  21. Dinh T, Tecilazich F, Kafanas A, et al. Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes. 2012;61(11):2937–2947.
  22. Levi M, van der Poll T, Büller HR. Bidirectional relation between inflammation and coagulation. Circulation. 2004;109(22):2698–2704.
  23. van der Wal AC, Becker AE. Atherosclerotic plaque rupture: Pathologic basis of plaque stability and instability. Cardiovasc Res. 1999;41(2):334–344.
  24. Li A, Dubey S, Varney ML, Dave BJ, Singh RK. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol. 2003;170(6):3369–3376.
  25. Moreau M, Brocheriou I, Petit L, Ninio E, Chapman MJ, Rouis M. Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: Relevance to stability of atherosclerotic plaque. Circulation. 1999;99(3):420–426.
  26. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16(5):585–601.
  27. Ait-Oufella H, Taleb S, Mallat Z, Tedgui A. Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol. 2011;31(5):969–979.
  28. Bromley SK, Mempel TR, Luster AD. Orchestrating the orchestrators: Chemokines in control of T cell traffic. Nat Immunol. 2008;9(9):970–980.
  29. de Jager SC, Bongaerts BW, Weber M, et al. Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes. PLoS One. 2012;7(9):e45804.
  30. Robson MC. The role of growth factors in the healing of chronic wounds. Wound Rep Reg. 1997;5(1):512–517.
  31. Sapienza P, di Marzo L, Borrelli V, et al. Basic fibroblast growth factor mediates carotid plaque instability through metalloproteinase-2 and -9 expression. Eur J Vasc Endovasc Surg. 2004;28:89–97.
  32. Petreaca ML, Yao M, Ware C, Martins-Green MM. Vascular endothelial growth factor promotes macrophage apoptosis through stimulation of tumor necrosis factor superfamily member 14 (TNFSF14/LIGHT). Wound Repair Regen. 2008;16(5):602–614.
  33. Steffel J, Lüscher TF, Tanner FC. Tissue factor in cardiovascular diseases: Molecular mechanisms and clinical implications. Circulation. 2006;113(5):722–731.
  34. Morceau F, Dicato M, Diederic M. Pro-inflammatory cytokine-mediated anemia: Regarding molecular mechanisms of erythropoiesis. Mediators Inflamm. 2009;2009:405016.
  35. Salmon-Ehr V, Ramont L, Godeau G, et al. Implication of interleukin-4 in wound healing. Lab Invest. 2000;80(8):1337–1343.
  36. Dehne N, Tausendschön M, Essler S, Geis T, Schmid T, Brüne B. IL-4 reduces the proangiogenic capacity of macrophages by down-regulating HIF-1α translation. J Leukoc Biol. 2014;95(1):129–137.
  37. Ahdieh M, Vandenbos T, Youakim A. Lung epithelial barrier function and wound healing are decreased by IL-4 and IL-13 and enhanced by IFN-g. Am J Physiol Cell Physiol. 2001;281(6):C2029–2038.
  38. Cianfarani F, Tommasi R, Failla CM, et al. Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed. Br J Dermatol. 2006;154(1):34–41.
  39. Dogra S, Sarangal R. Summary of recommendations for leg ulcers. Indian Dermatol Online J. 2014;5(3):400–407.
  40. Beidler SK, Douillet CD, Berndt DF, Keagy BA, Rich PB, Marston WA. Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy. J Vasc Surg. 2009;49(4):1013–1020.